Oncolytic viruses could be used to ‘warm up’ cold tumors and improve immunotherapy

Equipping cancer-infecting, or oncolytic, viruses with tumor-inhibiting genetic cargo stimulates the immune system and helps immunotherapy to shrink or completely clear aggressive tumors in mice, according to a new study in the Journal of Experimental Medicine led by University of Pittsburgh and UPMC researchers.

Destiny Pharma plc shares now trading on JP Jenkins – Biotech Investments

JP Jenkins Ltd Destiny Pharma plc shares now trading on JP Jenkins 13-Aug-2024 / 09:36 GMT/BST The issuer is solely responsible for the content of

August 14, 2024

Centinel Spine to sell fusion business, focus on disc replacement

Dive Brief: Centinel Spine, a privately held medical device maker based in West Chester, Pennsylvania, said it has agreed to sell its spinal fusion portfolio

September 11, 2023

‘People want vanilla ice cream’: CEO Anne Wojcicki grapples with 23andMe’s dual identity

SAN FRANCISCO — 23andMe CEO Anne Wojcicki said she’s “open to all ideas” in addressing investor confusion and turning around a disappointing start to the genomic

January 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.